8/8/1999 • Antidepressant discontinuation-related mania: critical prospective observation and theoretical implications in bipolar disorder.

8/8/1999 • Antidepressant discontinuation-related mania: critical prospective observation and theoretical implications in bipolar disorder. Goldstein TR, Frye MA, Denicoff KD, Smith-Jackson E, Leverich GS, Bryan AL, Ali SO, Post RM Department of Clinical Psychology, University of Colorado, Boulder, USA. J Clin Psychiatry 1999 Aug 60(8); 563-7 quiz 568-9 These 6 cases suggest a paradoxical effect…

Read More

6/1/1999 • Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid.

6/1/1999 • Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid. Martensson B, Nyberg S, Toresson G, Brodin E, Bertilsson L Department of Psychiatry, Karolinska Hospital, Stockholm, Sweden. Acta Psychiatr Scand 1989 Jun; 79(6); 586-96 During treatment the 5-HIAA concentration decreased by 46%. Fluoxetine treatment…

Read More

9/1/1998 • Prenatal Exposure to Fluoxetine (Prozac) Produces Site-Specific and Age-Dependent Alterations in Brain Serotonin Transporters in Rat Progeny: Evidence from Autoradiographic Studies

9/1/1998 • Prenatal Exposure to Fluoxetine (Prozac) Produces Site-Specific and Age-Dependent Alterations in Brain Serotonin Transporters in Rat Progeny: Evidence from Autoradiographic Studies Theresa M. Cabrera-Vera2 and George Battaglia Department of Pharmacology and Experimental Therapeutics, Loyola University of Chicago, Stritch School of Medicine, Maywood, Illinois Pharmacology; Vol. 286 Issue 3, 1474-1481, September 1998 The age-dependent…

Read More

2/17/1997 • Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors.

2/17/1997 • Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors. Sheline Y, Bardgett ME, Csernansky JG Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri 63110, USA. J Clin Psychopharmacol 1997 Feb 17 1 11-4 Drug treatment, overall, was associated with significant decreases in 5-HIAA…

Read More

7/23/1996 • Effect of acute and chronic fluoxetine on extracellular dopamine levels in the caudate-putamen and nucleus accumbens of rat.

7/23/1996 • Effect of acute and chronic fluoxetine on extracellular dopamine levels in the caudate-putamen and nucleus accumbens of rat. Clark RN, Ashby CR Jr, Dewey SL, Ramachandran PV, Strecker RE Department of Psychiatry and Behavioral Sciences, State University of New York at Stony Brook 11794, USA. Synapse 1996; Jul; 23 (3); 125-31 Extracellular levels…

Read More

4/15/1993 • Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.

4/15/1993 • Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers. De Bellis MD, Geracioti TD Jr, Altemus M, Kling MA Clinical Neuroendocrinology Branch, National Institute of Mental Health,National Institute of Health, Bethesda, Maryland. Biol Psychiatry 1993 Apr 15-May 1; 33 (8-9); 636-41 CSF 5-HIAA and MHPG decreased significantly… following…

Read More

5/17/1975 • Fenfluramine in man: hypophagia associated with diminished serotonin turnover.

5/17/1975 • Fenfluramine in man: hypophagia associated with diminished serotonin turnover. Shoulson I, Chase TN Clin Pharmacol Ther 1975 May 17(5) 616-21 The results support the contention that the effect of fenfluramine on human dietary intake may be mediated by alterations in serotonergic rather than dopaminergic mechanisms. Fenfluramine in man: hypophagia associated with diminished serotonin…

Read More